FDA 483 - Memorial Sloan Kettering Cancer Center - November 09, 2018
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Memorial Sloan Kettering Cancer Center in New York, NY, underwent a GLP inspection that identified significant deficiencies. Observations included inadequate validation of analytical methods for determining test article concentrations, a study director's failure to address unforeseen circumstances impacting study integrity, and a quality assurance unit that did not accurately review final study reports against raw data. These findings indicate a lack of adherence to Good Laboratory Practices in their nonclinical laboratory studies.
ID · c1454d69-c1e7-4125-821f-cfdcd5073540